Showing results for "Health Care" in Computers & Technology

Medicine has become inhuman, to disastrous effect. The doctor-patient relationship - the heart of medicine - is broken: doctors are too distracted and overwhelmed to truly connect with their patients, and medical errors and misdiagnoses abound. In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help. AI has the potential to transform everything doctors do, from notetaking and medical scans to diagnosis and treatment, greatly cutting down the cost of medicine and reducing human mortality.

Large language models (LLMs) and generative AI are rapidly changing the healthcare industry. These technologies have the potential to revolutionize healthcare by improving the efficiency, accuracy, and personalization of care. This practical book shows healthcare leaders, researchers, data scientists, and AI engineers the potential of LLMs and generative AI today and in the future, using storytelling and illustrative use cases in healthcare.

In The Patient Will See You Now, Eric Topol, one of the nation's top physicians, examines what he calls medicine's "Gutenberg moment". Much as the printing press liberated knowledge from the control of an elite class, new technology is poised to democratize medicine. In this new era, patients will control their data and be emancipated from a paternalistic medical regime in which "the doctor knows best."

According to estimates, the healthcare AI market will grow to over $45 billion by 2026. Now is the time for everyone involved, including medical consumers and entrepreneurs, to understand and embrace the AI in healthcare revolution. AI continues to advance at breakneck speeds. Nowhere else is AI moving faster than in the health care sector, where it’s being used to improve millions of lives at every point in the healthcare system. In this book, you will take a deep dive into the remarkable strides that AI is making.

JAK UPÓR I TROCHĘ SZCZĘŚCIA ZMIENIŁY ŚWIAT Czy wiesz, że: miniaturowy odłamek plastiku w oku pilota RAF-u sprawił, że dziś używamy tego materiału do produkcji sztucznych soczewek; tytanowa komora, która za nic nie dawała usunąć się z kości królika, doprowadziła do powstania implantów dentystycznych; viagrę zawdzięczamy grupie chemików pracujących nad nowym lekiem mającym przynieść ulgę cierpiącym z powodu dusznicy bolesnej; pięć wyjątkowo ciepłych tygodni 1928 roku pomogło Alexandrowi Flemingowi w odkryciu penicyliny.

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health, while contributing trillions of dollars to the global economy. In spite of these past successes - and indeed because of them - our ability to deliver new medicines may be quickly coming to an end. Moving from the 20th century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.

Our health care system is crippled by desperate efforts to prevent the inevitable. A third of the national Medicare budget - nearly $175 billion - is spent on the final year of life, and a third of that amount on the final month, often on expensive (and futile) treatments. Such efforts betray a fundamental flaw in how we think about healthcare: we squander resources on hopeless situations, instead of using them to actually improve health.

Already technology enables parents to select some genetic traits for their children, and soon it will be possible to begin to shape ourselves as a species. Countering loud cries of alarm, bioethics expert Ronald Green explains why our fears about genetic engineering are overblown and how we can move forward responsibly to create a better future.

Brought to you by Penguin. Digital spaces are a positive force for change, connection and community, but left unregulated, they are not always safe. Globally, women are 27 times more likely than men to be harassed online. 78% of LGBTQ+ people have experienced hate crime and hate speech online...

Dr. Melanie Laidlaw is a scientist developing the first use of ICSI, short for intracytoplasmic sperm injection. Her collaborator, Dr. Felix Krankenthaler, turns out to have his own ideas about how to implement their new procedure. The wild card is Melanie's new lover, Menachem Dvir, a fellow scientist. This darkly comic ménage à trois plays out not only in bedrooms and labs, but also in test tubes and under the microscope. A Brave New World indeed!